Parathyroid carcinoma in a chronic hemodialysis patient: Case report and review of the literature

被引:16
作者
Bossola, Maurizio
Tazza, Luigi
Ferrante, Angela
Giungi, Stefania
Carbone, Arnaldo
Gui, Daniele
Luciani, Giovanna
机构
[1] Univ Cattolica Sacro Cuore, Ist Clin Chirurg, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Ist Anat Patol, I-00168 Rome, Italy
来源
TUMORI JOURNAL | 2005年 / 91卷 / 06期
关键词
hemodialysis; parathyroid carcinoma; parathyroidectomy;
D O I
10.1177/030089160509100619
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Parathyroid carcinoma is a rare disease in normal population as well as in patients with end-stage renal disease. Approximately 700 cases have been reported and, of these, 20 occurred in patients receiving chronic hemodialysis. We describe a case of parathyroid carcinoma in a 59-year-old female patient with end-stage renal disease secondary to membranous glomerulonephritis treated by hemodialysis since 1995. In September 1998, the calcium level was 12.4 mg/dl and intact parathyroid hormone serum levels were 1366 pg/ml (normal range, 25-65). A routine ultrasonographic examination of the neck revealed enlargement of two parathyroid glands, the left inferior gland being the largest and measuring 2x3x2 cm. In October 1998, resection of two parathyroid glands was performed. On the basis of histology, which documented the presence of proliferating cells arranged in sheets or in a trabecular pattern, numerous mitosis and vascular invasion, a diagnosis of parathyroid carcinoma was made.
引用
收藏
页码:558 / 562
页数:5
相关论文
共 41 条
[1]  
ANDERSON BJ, 1983, SURGERY, V94, P906
[2]  
AUGUST DA, 1993, SURGERY, V113, P290
[3]  
BERLAND Y, 1982, CLIN NEPHROL, V18, P154
[4]   HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome [J].
Carpten, JD ;
Robbins, CM ;
Villablanca, A ;
Forsberg, L ;
Presciuttini, S ;
Bailey-Wilson, J ;
Simonds, WF ;
Gillanders, EM ;
Kennedy, AM ;
Chen, JD ;
Agarwal, SK ;
Sood, R ;
Jones, MP ;
Moses, TY ;
Haven, C ;
Petillo, D ;
Leotlela, PD ;
Harding, B ;
Cameron, D ;
Pannett, AA ;
Höög, A ;
Heath, H ;
James-Newton, LA ;
Robinson, B ;
Zarbo, RJ ;
Cavaco, BM ;
Wassif, W ;
Perrier, ND ;
Rosen, IB ;
Kristoffersson, U ;
Turnpenny, PD ;
Farnebo, LO ;
Besser, GM ;
Jackson, CE ;
Morreau, H ;
Trent, JM ;
Thakker, RV ;
Marx, SJ ;
Teh, BT ;
Larsson, C ;
Hobbs, MR .
NATURE GENETICS, 2002, 32 (04) :676-680
[5]  
Chudek J, 1998, CLIN CANCER RES, V4, P211
[6]   RECURRENT HYPERPARATHYROIDISM [J].
CLARK, OH ;
WAY, LW ;
HUNT, TK .
ANNALS OF SURGERY, 1976, 184 (04) :391-402
[7]   Parathyroid carcinoma: Evaluation and interdisciplinary management [J].
Clayman, GL ;
Gonzalez, HE ;
El-Naggar, A ;
Vassilopoulou-Sellin, R .
CANCER, 2004, 100 (05) :900-905
[8]   LOSS OF THE RETINOBLASTOMA TUMOR-SUPPRESSOR GENE IN PARATHYROID CARCINOMA [J].
CRYNS, VL ;
THOR, A ;
XU, HJ ;
HU, SX ;
WIERMAN, ME ;
VICKERY, AL ;
BENEDICT, WF ;
ARNOLD, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (11) :757-761
[9]  
Djema AI, 1998, NEPHROLOGIE, V19, P121
[10]  
Drüeke TB, 2000, J AM SOC NEPHROL, V11, P1141, DOI 10.1681/ASN.V1161141